Search:
Filter:
Sort:
As of the first week of January, we found several companies with multiple ads still running well past its self-imposed deadline. Google can do better, but will they?
The FDA has posted notices for two nationwide dietary supplement recalls involving products found to contain undeclared pharmaceutical ingredients.
New York found widespread safety violations in med spas, and FDA inspectors cited a Texas distributor for violating the DSCSA.
Our analysis of data in September and October 2025 revealed that large-scale freight fraud involving GLP-1s, oncology drugs, and other high-demand pharmaceuticals continues unabated.
Prescription Drug Affordability Board Activity, November 2025 Activities Summary Colorado: In October, Colorado’s PDAB heard testimony about its decision to set an upper payment limit on Enbrel, and set price of $600 per 50mg/1ml, effective January 1, 2027. The board’s next meeting is January 9, 2026. Maryland:The PDAB met on November 17, 2025 where they passed motions to identify Ozempic…
Based on recent investigative reporting by the Partnership for Safe Medicines (PSM), patients in your state may be receiving weight loss injectables from unlicensed sources that do not meet FDA requirements for safety and sterility. PSM has established a dedicated contact from CBP/HSI to support investigations by state law enforcement on this issue.
CBP reported seizing 450 shipments of illegally imported contact lenses and prescription medicines. Dozens of state AGs asked Meta to enforce policies against misleading weight loss products.
The med spa owner admitted to using unapproved injectables that sickened at least 10 patients. New York authorities announced the results of a 2024 crackdown on illegal med spas. PSM published in The Journal of Illicit Trade, Financial Crime, and Compliance.
PSM wrote the House Energy & Commerce Committee in support of the Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act, to help protect the American drug supply from unsafely compounded medication.
FDA announced the seizure of dozens of counterfeit Ozempic 1mg injection pens labeled with an authentic lot number, PAR1229, but displaying the expiration and lot numbers for the product in the wrong place.